CollPlant Biotechnologies Ltd.
CLGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $41 | $73 | $92 | $163 |
| - Cash | $12 | $27 | $30 | $13 |
| + Debt | $3 | $3 | $3 | $4 |
| Enterprise Value | $32 | $49 | $65 | $154 |
| Revenue | $1 | $11 | $0 | $16 |
| % Growth | -95.3% | 3,565.2% | -98.1% | – |
| Gross Profit | -$2 | $8 | -$1 | $14 |
| % Margin | -417.1% | 71.8% | -393.6% | 87.2% |
| EBITDA | -$16 | -$6 | -$16 | $1 |
| % Margin | -3,020.2% | -53.9% | -5,289.3% | 6.7% |
| Net Income | -$17 | -$7 | -$17 | $0 |
| % Margin | -3,225% | -64% | -5,660.5% | 1.5% |
| EPS Diluted | -1.45 | -0.62 | -1.52 | 0.034 |
| % Growth | -133.9% | 59.2% | -4,544.4% | – |
| Operating Cash Flow | -$14 | -$3 | -$14 | $3 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$15 | -$4 | -$15 | $1 |